Ramiro A. Ramirez-Valdez
University of Oxford(GB)Ludwig Cancer Research(GB)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, T-cell and B-cell Immunology
Most-Cited Works
- → Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens(2020)328 cited
- → Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment(2022)217 cited
- → Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells(2020)199 cited
- → Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction(2019)41 cited
- → Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates(2019)38 cited
- → Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy(2021)28 cited
- → Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression(2023)27 cited
- → Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice(2024)1 cited
- → Intravenous Vaccination Induces CD8 <sup>+</sup> T Cells and Type I IFN-Dependent Remodeling of the Tumor Microenvironment(2022)
- → Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+CD8+ T cells(2023)